| Followers | 21 |
| Posts | 946 |
| Boards Moderated | 0 |
| Alias Born | 07/20/2020 |
Thursday, October 20, 2022 11:59:08 AM
I read through the posts. I don't even know what to think anymore, but that fellow, Bobster, did a phenomenal job laying out his argument. I just don't know what is fact or fiction. It seems like the endpoints are simple, but we have to trust that MF knows what he is doing. Guys like him don't like to be wrong and then submit what a semi-credentialed BMT guy said all along. MF's ego would be crushed. MF must be pretty confident that this will go through. Me? I really don't know, but I will say this. Bucy works so someone will buy it for more than $.18 if RVVTF runs into a snag. Ready to brace for a drop if we have to resubmit but have accepted the fact that I will be holding longer than predicted.
ps. Can I get a "we wait"?
ps. Can I get a "we wait"?
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
